US Stock MarketDetailed Quotes

BBLGW BONE BIOLOGICS CORP C/WTS (TO PUR COM)

Watchlist
  • 25.0100
  • +6.0100+31.63%
Close Apr 18 16:00 ET
0Market Cap0.00P/E (TTM)

BONE BIOLOGICS CORP C/WTS (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
0
0
0
0
Gross profit
0
0
0
0
0
0
Operating expense
157.24%9.43M
-9.87%1.16M
70.67%2.08M
547.74%3.04M
356.50%3.15M
232.27%3.67M
179.51%1.29M
430.61%1.22M
102.39%469.3K
281.10%689.5K
Selling and administrative expenses
20.84%2.52M
34.21%712.93K
12.49%506.04K
64.85%744.62K
-14.73%556.89K
104.29%2.09M
24.71%531.21K
95.77%449.87K
96.51%451.7K
382.26%653.1K
-General and administrative expense
20.84%2.52M
34.21%712.93K
12.49%506.04K
64.85%744.62K
-14.73%556.89K
104.29%2.09M
24.71%531.21K
95.77%449.87K
96.51%451.7K
382.26%653.1K
Research and development costs
337.40%6.91M
-40.85%447.08K
104.68%1.57M
12,941.20%2.3M
7,017.16%2.59M
1,824.94%1.58M
2,089.20%755.89K
--769.41K
773.02%17.6K
-20.00%36.4K
Operating profit
-157.24%-9.43M
9.87%-1.16M
-70.67%-2.08M
-547.74%-3.04M
-356.50%-3.15M
-232.27%-3.67M
-179.51%-1.29M
-430.61%-1.22M
-102.39%-469.3K
-281.10%-689.5K
Net non-operating interest income expense
100.26%1.87K
100.05%349
536
428
556
9.12%-731.71K
-4,859.09%-731.71K
0
0
0
Non-operating interest income
--1.87K
--349
--536
--428
--556
--0
--0
--0
--0
--0
Total other finance cost
----
----
----
----
----
--731.71K
----
----
----
----
Other net income (expense)
-83.60%477.7K
-390.23K
160.65K
1.27M
-562.92K
878.91%2.91M
Gain on sale of security
-69.35%892.69K
--24.76K
--160.65K
--1.27M
---562.92K
--2.91M
----
----
----
----
Special income (charges)
---414.99K
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--414.99K
----
----
----
----
----
----
----
----
----
Income before tax
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
4.59%-469.3K
-59.70%-689.5K
Income tax
Net income
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
4.59%-469.3K
-59.70%-689.5K
Net income continuous Operations
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
4.59%-469.3K
-59.70%-689.5K
Minority interest income
Net income attributable to the parent company
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
4.59%-469.3K
-59.70%-689.5K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
4.59%-469.3K
-59.70%-689.5K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 000000
Gross profit 000000
Operating expense 157.24%9.43M-9.87%1.16M70.67%2.08M547.74%3.04M356.50%3.15M232.27%3.67M179.51%1.29M430.61%1.22M102.39%469.3K281.10%689.5K
Selling and administrative expenses 20.84%2.52M34.21%712.93K12.49%506.04K64.85%744.62K-14.73%556.89K104.29%2.09M24.71%531.21K95.77%449.87K96.51%451.7K382.26%653.1K
-General and administrative expense 20.84%2.52M34.21%712.93K12.49%506.04K64.85%744.62K-14.73%556.89K104.29%2.09M24.71%531.21K95.77%449.87K96.51%451.7K382.26%653.1K
Research and development costs 337.40%6.91M-40.85%447.08K104.68%1.57M12,941.20%2.3M7,017.16%2.59M1,824.94%1.58M2,089.20%755.89K--769.41K773.02%17.6K-20.00%36.4K
Operating profit -157.24%-9.43M9.87%-1.16M-70.67%-2.08M-547.74%-3.04M-356.50%-3.15M-232.27%-3.67M-179.51%-1.29M-430.61%-1.22M-102.39%-469.3K-281.10%-689.5K
Net non-operating interest income expense 100.26%1.87K100.05%3495364285569.12%-731.71K-4,859.09%-731.71K000
Non-operating interest income --1.87K--349--536--428--556--0--0--0--0--0
Total other finance cost ----------------------731.71K----------------
Other net income (expense) -83.60%477.7K-390.23K160.65K1.27M-562.92K878.91%2.91M
Gain on sale of security -69.35%892.69K--24.76K--160.65K--1.27M---562.92K--2.91M----------------
Special income (charges) ---414.99K------------------0----------------
-Less:Other special charges --414.99K------------------------------------
Income before tax -502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M4.59%-469.3K-59.70%-689.5K
Income tax
Net income -502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M4.59%-469.3K-59.70%-689.5K
Net income continuous Operations -502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M4.59%-469.3K-59.70%-689.5K
Minority interest income
Net income attributable to the parent company -502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M4.59%-469.3K-59.70%-689.5K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M4.59%-469.3K-59.70%-689.5K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg